Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation

01.05.2024 - Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) - Continued expansion of IP portfolio related to RNA delivery  Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira ... Seite 1

Related Keywords

United States ,Bermuda ,Covadonga Pa ,United States Patent Office ,Company Nasdaq ,Development Officer ,Company Oligophore ,Altamira Therapeutics Ltd ,Altamira Therapeutics ,Altamira Therapeutic Chief Development ,